Neovasc is focused on bringing its Reducer coronary device to the US to treat cardiac angina – chest pain caused by a lack of blood flow to the heart muscle.
Neovasc Plans ‘Two Shots On Goal’ For Reducer To Treat Angina
Neovasc’ COO Bill Little talked to Medtech Insight about the company’s plans to develop its Reducer transcatheter device to treat cardiac angina associated with or without obstructive coronary disease.
